MKI67 and neoplasm: Since our in vivo studies revealed a significant reduction in tumor growth in the combined treatment group of Doc and SnPP compared to the other groups, we investigated the effect of the HO-1 inhibition on the expression level of Ki67, a biomarker strongly associated with cell proliferation and progression in PC [65].